跳至主要内容
临床试验/ACTRN12610000913077
ACTRN12610000913077已完成3 期

Efficacy of artesunate-pyronaridine and artemisinin-naphthoquine combination therapies compared with standard artemether-lumefantrine in children from Papua New Guinea with uncomplicated malaria who are monitored for recurrent malaria over 42 days post-treatment

niversity of Western Australia0 个研究点目标入组 637 人开始时间: 2010年10月26日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
637

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
Years 至 5 Years(—)
性别
All

入选标准

  • Children with an axillary temperature >37.5 degrees Centigrade or fever during the previous 24 hours with either P. falciparum (>1000 asexual parasites per microlitre whole blood) or P. vivax (>250 per microlitre) on blood smear microscopy

排除标准

  • Features of severity, treatment with a study drug or other antimalarial in the previous 28 days, clinical or laboratory evidence of another infection or co-morbidity including malnutrition

研究者

发起方
niversity of Western Australia

相似试验